NPR News: Drug To Prevent Premature Birth Divides Doctors, Insurers And FDA Experts
Drug To Prevent Premature Birth Divides Doctors, Insurers And FDA Experts
An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug disagree.
Read more on NPR
An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug disagree.
Read more on NPR
Comments
Post a Comment